|
Assessing the benefit of adjuvant endocrine therapy in patients following breast-conserving surgery with or without radiation stratified by a 7-gene predictive DCIS biosignature. |
| |
|
Employment - Integra LifeSciences (I) |
Leadership - Integra LifeSciences (I) |
Stock and Other Ownership Interests - Integra LifeSciences (I); Targeted Medical Education, Inc. |
Honoraria - Puma Biotechnology |
Consulting or Advisory Role - Becton Dickinson; ImpediMed; Prelude Therapeutics |
Research Funding - Agendia; Medneon; Prelude Therapeutics |
Travel, Accommodations, Expenses - Targeted Medical Education, Inc. |
| |
|
Employment - Cleveland Clinic |
Consulting or Advisory Role - eviCore healthcare; ImpediMed; PreludeDx; Videra Surgical |
Research Funding - PreludeDx; PreludeDx; Varian Medical Systems; Vision RT |
| |
|
Employment - 21st Century Oncology |
Consulting or Advisory Role - ImpediMed; Prelude Therapeutics |
Travel, Accommodations, Expenses - Concure Oncology Breast Microseed; PreludeDx |
| |
|
No Relationships to Disclose |
| |
|
No Relationships to Disclose |
| |
|
Consulting or Advisory Role - PreludeDx |
Research Funding - PreludeDx (Inst) |
| |
|
No Relationships to Disclose |
| |
|
Research Funding - PreludeDx |
| |
|
Research Funding - PreludeDx |
| |
|
Research Funding - PreludeDx (Inst) |
| |
|
Stock and Other Ownership Interests - PreludeDx |
Consulting or Advisory Role - PreludeDx |
| |
|
Stock and Other Ownership Interests - PreludeDx |
Consulting or Advisory Role - PreludeDx |
| |
|
|
Stock and Other Ownership Interests - PreludeDx |
| |
|
|
Stock and Other Ownership Interests - PreludeDx |
| |
|
|
|
Stock and Other Ownership Interests - PreludeDx |
Patents, Royalties, Other Intellectual Property - PreludeDx |